Transforming our clients' challenges through leading edge AI/ML solutions.
We solve our Nation’s security challenges and our commercial clients’ most complex problems with cutting-edge AI/ML solutions and products.
Mission / Vision
GGI is a Delaware-registered Service-Disabled Veteran Owned Small Business founded in 2020.
Our mission is to solve our Nation’s most challenging security problems with cutting-edge AI/ML solutions and products. We are dedicated to elevating national security by enhancing force preservation and projection, organizational efficiency, process optimization, as we improve operational delivery for our Federal, State, and Commercial clients.
Our flagship application, Curo46™, is a revolutionary machine learning platform capable of analyzing and delivering solutions for both biological systems (bacteria to humans) and man-made systems (cybersecurity to supply chains) through our proprietary data sets and LLMs. Curo46™ enhances predictive health risk management, reduces inefficiencies, streamlines operations, and improves overall outcomes. With its advanced capabilities, Curo46™ stands at the forefront of innovation across diverse sectors.
What we do?
We create
- Analytical Al/ML tools to understand and optimize biological and man-made systems.
- Structured data from unstructured data
- Actionable solutions from chaotic problems
- Analyze systems, processes, and workflows and produce optimized solutions,
- AI products tailored to our U.S. Government, State, and Commercial clients mission.
- AI-driven national security solutions to both protect, preserve, and project the U.S. joint force to deter threats against all enemies foreign and domestic.
AI-Driven National Security
Empowering National Defense with Cutting-Edge AI/ML Solutions
At General Genomics, Inc., we endeavor to empower our national defense community with the highest quality AI and ML solutions because we believe in the importance of enhancing the joint warfighters’ capabilities to deter and, when necessary, defeat the pacing threats.
We are driven by a commitment to ensuring our nation’s defense is robust and adaptive, leveraging cutting-edge technology to give our servicemen and servicewomen a decisive edge.
Our dedication to improving operational efficiency, reducing risks, and enhancing decision-making on and off the battlefield stems from our deep respect and support for those who defend our freedom.
We are passionate about the safety and success of our military personnel, ensuring they return home ready to continue their mission and reunite with their families. By providing innovative AI/ML technologies, we aim to honor and support those who safeguard our nation.
A fully integrated, customized solution for government agencies.
Health and Medical Capabilities
General Genomics, Inc. (GGI) enhances healthcare outcomes through advanced AI-driven predictive analytics. Leveraging our proprietary data lake with over 600 million records, we provide early health issue detection and optimize medical readiness. Our predictive algorithms support proactive health management, ensuring forces remain in peak condition and enhancing operational readiness.
We have three patents pending that are centered on innovative machine learning technology designed to identify illnesses and diseases across all living organisms, from bacteria to humans.
GGI drives precision medicine and genomic research by analyzing extensive data from our proprietary data lake. Our tailored medical treatments based on individual genetic profiles offer highly personalized healthcare solutions, improving recovery rates and overall health for military personnel, thus supporting sustained force preservation.
We have three patents pending that are centered on innovative machine learning technology designed to identify illnesses and diseases across all living organisms, from bacteria to humans.
GGI enhances clinical decision-making with sophisticated decision support systems powered by AI. Our solutions, informed by a vast clinical data repository, assist healthcare providers in delivering accurate, data-driven care. This ensures optimal outcomes and maintains the operational effectiveness of military and civilian health services.
We have three patents pending that are centered on innovative machine learning technology designed to identify illnesses and diseases across all living organisms, from bacteria to humans.
We provide cutting-edge remote health monitoring and telemedicine solutions through AI/ML technologies. GGI offers real-time health insights and virtual consultations, ensuring continuous healthcare support for deployed and remote personnel, which is crucial for maintaining their health and operational effectiveness.
GGI accelerates drug development and therapeutics with AI/ML technologies. Our extensive data lake enables the identification of novel drug targets and optimization of therapeutic regimens, enhancing recovery and health outcomes for military personnel, thus supporting operational readiness.
We have three patents pending that are centered on innovative machine learning technology designed to identify illnesses and diseases across all living organisms, from bacteria to humans.
Biosecurity and Surveillance
GGI enhances national security through AI/ML algorithms for comprehensive biosurveillance and biosecurity. Our analysis of clinical and genomic data enables proactive identification and assessment of potential biological threats, ensuring timely interventions and robust response strategies.
Our AI/ML models offer precise epidemiological forecasts by simulating the spread of infectious diseases. This capability supports effective containment strategies and enhances the protection of military and civilian populations from potential outbreaks.
We have three patents pending that are centered on innovative machine learning technology designed to identify illnesses and diseases across all living organisms, from bacteria to humans.
GGI excels in detecting and responding to biological threats through advanced AI/ML algorithms. By analyzing real-time data from our data lake, we identify and assess pathogens and toxins, ensuring proactive and effective responses to safeguard public health and national security.
Data and Analytics
GGI leverages bioinformatics and big data analytics to process and interpret vast biological datasets. Our capabilities support critical decisions across DOD, HHS, DHS, Intel Community, USDA, FDA, and NASA, enabling rapid and informed responses to emerging threats and challenges.
We drive innovation in life sciences and clinical research using our extensive data lake. GGI develops solutions to complex medical challenges, improving the health and performance of military personnel and ensuring resilience in joint forces.
We have three patents pending that are centered on innovative machine learning technology designed to identify illnesses and diseases across all living organisms, from bacteria to humans.
Security and Identity Management
GGI provides cutting-edge biometrics and identity management solutions, leveraging advanced AI/ML technologies. Our systems offer robust biometric identification and verification, securing sensitive installations and ensuring personnel integrity, crucial for deterring both foreign and domestic threats.
We enhance cybersecurity with AI/ML technologies designed to detect and mitigate cyber threats in real-time. GGI’s solutions protect sensitive data and critical infrastructure, ensuring the security and integrity of national defense operations.
Logistics and Maintenance
GGI enhances logistics through AI/ML-driven supply chain risk management. Our data-driven insights predict potential disruptions, ensuring the continuous flow of critical resources and supporting lifecycle maintenance workflows, thereby optimizing military readiness.
We optimize enterprise-fleet maintenance using AI/ML technologies. By leveraging predictive analytics from our extensive data lake, GGI improves maintenance scheduling and extends asset lifecycles, ensuring that military fleets and equipment remain in top operational condition.
GGI supports military readiness with AI/ML solutions for medical logistics and asset tracking. Our technology optimizes the distribution and management of medical supplies and equipment, ensuring timely access and enhancing operational effectiveness.
Human Performance
At General Genomics, Inc. (GGI), we are dedicated to maximizing human performance for military personnel through advanced AI/ML-driven solutions. Our approach integrates comprehensive data analysis and cutting-edge technologies to enhance the physical, cognitive, and psychological readiness of service members.
GGI’s commitment to human performance optimization ensures that military personnel are equipped to excel in their missions, protecting their well-being while enhancing their operational effectiveness. Our solutions are designed to support and elevate the capabilities of service members, enabling them to perform at their best and achieve their mission objectives with confidence and efficiency.
We utilize AI to monitor and improve physical conditioning through personalized training programs. Our algorithms analyze data from various sources, including wearable sensors and health records, to optimize fitness regimens, prevent injuries, and enhance overall physical capabilities.
GGI’s solutions include AI-powered cognitive training and psychological support tools designed to boost mental resilience and decision-making skills. By leveraging insights from our extensive data lake, we develop tailored strategies to enhance focus, reduce stress, and improve cognitive function.
Our human performance solutions ensure that service members are well-prepared to operate at the highest levels of efficiency during missions. We provide real-time insights and adaptive strategies that help personnel quickly adjust to changing conditions and maintain peak performance throughout their roles.
We also focus on protective measures to safeguard service members from potential physical and psychological strain. Our AI/ML technologies identify early signs of fatigue or stress, enabling timely interventions to preserve health and maintain operational readiness.
Emerging Threats
GGI addresses emerging threats with advanced AI/ML-driven counter-drone technologies. Our systems are designed to detect, track, and neutralize hostile drones, ensuring the protection of critical assets and personnel from aerial threats.
Workforce Development
GGI equips professionals with advanced training in AI and Artificial General Intelligence (AGI) technologies. Our programs focus on designing and implementing large language models (LLMs) and integrating these technologies into large-scale enterprise workflows. This training enhances productivity and efficiency, ensuring that the workforce remains adept in evolving technological landscapes.
We drive workflow efficiency with AI-enhanced optimization training. GGI provides expertise in applying AI and AGI technologies to streamline processes and automate tasks, improving overall productivity and adapting to technological advancements.
Mapped NAICS
- 518210: Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- 541330: Engineering Services
- 541380: Testing Laboratories and Services
- 541511: Custom Computer Programming Services
- 541512: Computer Systems Design Services
- 541513: Computer Facilities Management Services
- 541519: Other Computer Related Services
- 541613: Process, Physical Distribution, and Logistics Consulting Services
- 541690: Other Scientific and Technical Consulting Services
- 541713: Research and Development in Nanotechnology
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- 541715: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 541720: Research and Development in the Social Sciences and Humanities
- 561621: Security Systems Services
- 611420: Computer Training
- 611430: Professional and Management Development Training
- 611519: Other Technical and Trade Schools
- 611699: All Other Miscellaneous Schools and Instruction
- 611710: Educational Support Services
- 621999: All Other Miscellaneous Ambulatory Health Care Services
AJ Rosenthal
President & CEO
AJ brings over twenty years of experience in engineering and business development to General Genomics. He is a multi-disciplinary product innovator and entrepreneur, with a track record of successfully bringing new products to a global market.
He is a decorated combat veteran who served as a Navy Nuclear Engineer for eight years, with multiple wartime tours in the Persian Gulf. He holds a BS in Nuclear Engineering Technologies, an MBA in Finance, and a Graduate Certificate in Leadership.
AJ Rosenthal
President
Warren Gieck
CTO Engineering & Product Development
Subhayan (Suby) Guha Thakurta
VP Engineering & Product Development
Shelley Klinger
VP Stakeholder Relations
Musheer Kakish
Business Development
Nick Noik
Talent Acquisition
Jeffrey E. Rothchild
Chief Marketing Officer
